Search Results - "Klochikhin, Mikhail"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    34762 Adjuvant pembrolizumab versus placebo in high-risk locally advanced cutaneous squamous cell carcinoma: The phase 3 KEYNOTE-630 study

    34762 Adjuvant pembrolizumab versus placebo in high-risk locally advanced cutaneous squamous cell carcinoma: The phase 3 KEYNOTE-630 study by Schenker, Michael, Klochikhin, Mikhail, Bratland, Ase, Kirtbaya, Dmitry, Guminski, Alexander, Dzienis, Marcin, Schmults, Chrysalyne, Ge, Joy Y., Yuan, Jianda, Lee, Jenny

    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    KEYNOTE-630: Phase 3 Study of Adjuvant Pembrolizumab in High-Risk Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC)

    KEYNOTE-630: Phase 3 Study of Adjuvant Pembrolizumab in High-Risk Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC) by Lee, Jenny, Dzienis, Marcin, Schmults, Chrysalyne, Schenker, Michael, Bratland, Åse, Klochikhin, Mikhail, Gifoni, Markus, Kirtbaya, Dmitry, Rivera-Diaz, Julian, Chipman, Mitchell, Geiger, Jessica L., Chang, Anne L.S., Daniels, Gregory A., Cohen, Ezra E.W., Yao, Lili, Gumuscu, Burak, Yuan, Jianda, Guminski, Alexander

    Published in European journal of surgical oncology (01-01-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Abstract PO-009: Phase 3 KEYNOTE-630 study of adjuvant pembrolizumab in high-risk locally advanced cutaneous squamous cell carcinoma

    Abstract PO-009: Phase 3 KEYNOTE-630 study of adjuvant pembrolizumab in high-risk locally advanced cutaneous squamous cell carcinoma by Schenker, Michael, Klochikhin, Mikhail, Kirtbaya, Dmitry, Mortier, Laurent, Gschnell, Martin, Robert, Caroline, Meyer, Nicolas, Flatz, Lukas, Dalle, Stephane, Beylot-Barry, Marie, Eigentler, Thomas, Silverman, Rachel Kloss, Gumuscu, Burak, Yuan, Jianda, Bratland, Aase

    Published in Clinical cancer research (15-09-2023)
    “…Introduction: Among patients with high-risk locally advanced (LA) cutaneous squamous cell carcinoma (cSCC), approximately 20% experience local disease…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: